Return On Equity	(Mar 31 2026) 2026	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Y / Y Equity Change	158.49 %	-72.38 %	-46.97 %	-30.42 %	-
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	52.23 %	-	-	-	-

PTIX all Ratios >> Back to PTIX Management Effectiveness >> See Quarterly PTIX Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Mar 31 2026) ROE improved to 52.23 % compare to previous year, due to net income growth.

Financial Statements
Protagenic Therapeutics Inc New's Equity	$ 3 Millions	Annual PTIX's Balance sheet
Protagenic Therapeutics Inc New's Annual Income	$ 1 Millions	Annual PTIX's Income Statement
Where are PTIX's Income coming from?		Visit PTIX's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.